The increasing popularity of novel psychoactive substances in the UK presents a considerable threat to public health. Often marketed online, these compounds frequently lack rigorous testing and their consequences are largely understood. Buying them carries a substantial risk of encountering dangerous adverse reactions, contamination, and potential